Figure 2

In vivo Bioluminescence assay and physical anatomy after operation. (a,b) PLC/PRF/5 and MHCC97-H groups on day 4 post-operation respectively. (c,d) PLC/PRF/5 and MHCC97-H groups on day 14 post-operation respectively. (e) Intrahepatic metastasis lesions of PLC/PRF/5 group. (f) Intrahepatic metastasis lesions of MHCC97-H group. (g) Comparison of liver weight between two groups. (h) Spleen orthotopic tumor of PLC/PRF/5 group. (i) Spleen orthotopic tumor of MHCC97-H group.